Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

Sanofi branded clouded background image

Latest Articles

a man breathing in a machine

What tests can help diagnose and monitor your patients with COPD?

Chronic Obstructive Pulmonary Disease (COPD) is typically suspected in patients with symptoms like dyspnea, chronic cough, or sputum production. Accurate diagnosis is crucial for effective management, with spirometry being essential for confirmation. Distinguishing COPD from similar conditions, such as asthma, is challenging yet vital. This article provides clear guidance on differentiating COPD from asthma and highlights key tools like spirometry and validated questionnaires for monitoring disease progression and guiding treatment. Understanding and applying these tools can significantly enhance patient outcomes in COPD management.

Learn more
A doctor holding a lungs hologram

GOLD Recommendations for Treatment and Management of COPD

Unveiling the Secrets to Optimal COPD Management: The GOLD Report Unraveled Imagine having a comprehensive guide that empowers you to take control of your COPD journey. The GOLD report, a beacon of knowledge, offers invaluable insights into diagnosing, managing, and treating this debilitating condition. This report leaves no stone unturned from tailored pharmacological therapies to groundbreaking non-pharmacological strategies. Discover how the GOLD ABE assessment tool, incorporating symptom evaluation and exacerbation risk, paves the way for personalized treatment plans. Unlock the power of eosinophil counts, a game-changer in predicting treatment responses, and embark on a transformative path toward better respiratory health.

Learn more
COPD and Type 2 Inflammation: exacerbation risk

An Overview of the impact of Type 2 Inflammation in COPD: Insights from Dr. Surya Bhatt

Chronic Obstructive Pulmonary Disease (COPD) remains a significant health challenge worldwide, characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities. Traditionally, COPD has been associated with neutrophil-driven inflammation, but recent insights suggest a more complex picture, involving Type 2 inflammation in a subset of patients. Dr. Surya Bhatt, a renowned COPD researcher and professor of medicine at the University of Alabama at Birmingham, provides valuable insights into this emerging area of COPD research.

Learn more